Parallel studies of mouse cell lines established from primary small B cell lymphomas (SBL), DBLL and splenic marginal zone lymphomas (MZL) showed that ARF-BP1 was expressed at uniquely high levels in MYC-driven DBLL (Figure 1B). The gene discussed is CDKN2A; the disease is marginal zone lymphoma.